InflaRx N.V. Profile Avatar - Palmy Investing

InflaRx N.V.

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of…
Biotechnology
DE, Jena [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Value per Employee (VpE)

InflaRx N.V. can't present you any valid VpE charts.

Employee Surveys Sample Size: -

There is no qualitative & current survey we can present at the moment.

Talent Acquisition

Permanent Employees Green Cards
Latest 12 Months
Employees
n/A
Wage Range
Min.:$n/A
Avg.:$n/A
Max.:$n/A
High Demand:

InflaRx N.V. can't present the data

Other Demand
  • Not available for InflaRx N.V.
Temporary Employees H1Bs
Latest 12 Months
Employees
n/A
Wage Range
Min.:$n/A
Avg.:$n/A
Max.:$n/A
High Demand:

InflaRx N.V. can't present the data

Other Demand
  • Not available for InflaRx N.V.

geographical
binding & acquisition

U.S. · Company Locations
Worldwide · Talent Acquisition
End of IFRX's Analysis
CIK: 1708688 CUSIP: N44821101 ISIN: NL0012661870 LEI: - UEI: -
Secondary Listings
IFRX has no secondary listings inside our databases.